Found: 8
Select item for more details and to access through your institution.
Substitution of Nevirapine because of Efavirenz Toxicity in AIDS Clinical Trials Group A5095.
- Published in:
- Clinical Infectious Diseases, 2010, v. 50, n. 5, p. 787, doi. 10.1086/650539
- By:
- Publication type:
- Article
Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 5, p. 642, doi. 10.1086/597007
- By:
- Publication type:
- Article
Detection of Nonnucleoside Reverse-Transcriptase Inhibitor—Resistant HIV-1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 2008, v. 47, n. 3, p. 421, doi. 10.1086/589867
- By:
- Publication type:
- Article
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Response to Vicriviroc in Treatment- Experienced Subjects, as Determined by an Enhanced-Sensitivity Coreceptor Tropism Assay: Reanalysis of AIDS Clinical Trials Group A5211.
- Published in:
- Journal of Infectious Diseases, 2009, v. 200, n. 11, p. 1724, doi. 10.1086/648090
- By:
- Publication type:
- Article
Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211.
- Published in:
- Journal of Infectious Diseases, 2007, v. 196, n. 2, p. 304, doi. 10.1086/518797
- By:
- Publication type:
- Article
Interruption of Antiretroviral Treatment in HIV-Infected Patients with Preserved Immune Function Is Associated with a Low Rate of Clinical Progression: A Prospective Study by AIDS Clinical Trials Group 5170.
- Published in:
- Journal of Infectious Diseases, 2007, v. 195, n. 10, p. 1426, doi. 10.1086/512681
- By:
- Publication type:
- Article
Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 8, p. 1231, doi. 10.1093/infdis/jit322
- By:
- Publication type:
- Article